ConoGenetix's Series A Round

ConoGenetix raised a round of funding on May 09, 2012. Investors include Mey Capital Matrix.

ConoGenetix focuses on the development of new peptide therapeutics for the treatment of autoimmune diseases.…

Articles about ConoGenetix's Series A Round: